Unlisted
| Company Name | 에이치엘비제넥스(주) |
| English Name | HLB Genex, Inc. |
| Business Reg. No. | 3148132185 |
| CEO | 김의중, 김도연 (각자 대표이사) |
| Address | 대전광역시 유성구 테크노1로 65(관평동) |
| Industry | 그 외 기타 분류 안된 화학제품 제조업 |
| Industry Code | 211 |
| Main Products | Lactase, Catalas, Lipase |
| Established | 20000329 |
| Phone | 042-862-4483 |
| Website | www.genofocus.com |
| Regular Employees | 78persons |
| Corp. Reg. No. | 1601110095821 |
Venture Certified
| 연구개발기업 | 2001-02-27 ~ 2003-02-26 | 20011522710986 | 2001-02-27 |
| 연구개발기업 | 2003-05-30 ~ 2005-05-29 | 031522021200110 | 2001-02-27 |
| 연구개발기업 | 2005-05-30 ~ 2007-05-29 | 051522021300220 | 2001-02-27 |
| 연구개발유형 | 2007-05-30 ~ 2009-05-29 | 20070101818 | 2001-02-27 |
| 연구개발유형 | 2009-05-30 ~ 2011-05-29 | 20090106890 | 2001-02-27 |
| 연구개발유형 | 2011-05-30 ~ 2013-05-29 | 20110104206 | 2001-02-27 |
| 연구개발유형 | 2013-05-30 ~ 2015-05-29 | 20130106869 | 2001-02-27 |
| 연구개발유형 | 2015-05-30 ~ 2017-05-29 | 20150103827 | 2001-02-27 |
| 연구개발유형 | 2017-05-30 ~ 2019-05-29 | 20170106547 | 2001-02-27 |
| 연구개발유형 | 2019-05-30 ~ 2021-05-29 | 20190105377 | 2001-02-27 |
| 연구개발유형 | 2021-05-30 ~ 2024-05-29 | 20210616020072 | 2001-02-27 |
| 연구개발유형 | 2024-05-30 ~ 2027-05-29 | 20240522020008 | 2001-02-27 |
Revenue CAGR +11.0%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 354B | 270B | 278B | 259B |
| Operating Profit | -19B | -95B | -62B | -38B |
| Net Profit | -179B | -7.2B | -134B | -85B |
| Total Assets | 1,463B | 979B | 1,339B | 1,185B |
| Total Liabilities | 1,180B | 715B | 1,068B | 797B |
| Total Equity | 282B | 264B | 271B | 388B |
Debt Ratio 418.3%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -19B
4 Consecutive Years of Net Loss
Debt Ratio Surge (+147pp YoY)
▲ 31.7%
▲ 71.2%
▲ 78.0%
▲ 44.0%
▼ 157.2%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 진양곤 | 사내이사 | 이사회 의장 | - |
| 김정현 | 미등기 | 연구총괄 | - |
| 진동현 | 감사 | 감사 | - |
| 김의중 | 사내이사 | 회사총괄 | - |
| 김도연 | 사내이사 | 회사총괄 | - |
| 김송수 | 사내이사 | 사내이사 | - |
| 심경재 | 사내이사 | 사내이사 | - |
| 김준형 | 사외이사 | 사외이사 | - |
| 이상백 | 사외이사 | 사외이사 | - |
| 고훈 | 사외이사 | 사외이사 | - |
| 반재구 | 미등기 | CTO | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 80persons |
| CEO | 김의중, 김도연 (각자 대표이사) |
| Est. Avg. Annual Salary | 4,82610K (40210K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -2persons |
| Net Change (12 mo) | -1persons |
| NPS Join Date | 2000-11-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "대전광역시 유성구 테크노1로",
"brno": "314813****",
"cappedWarning": false,
"companyName": "에이치엘비제넥스 주식회사 (HLB Genex, Inc.)",
"estimatedAvgAnnualSalary": 48260808,
"estimatedAvgMonthlySalary": 4021734,
"fetchedAt": "2026-03-05T11:45:53.871Z",
"industryCode": "241106",
"industryName": "석탄화학계 화합물 및 기타 기초 유기화학 물질제조업",
"joinDate": "20001101",
"last12MonthsHired": 1,
"last12MonthsLeft": 2,
"last12MonthsNetChange": -1,
"leaveDate": null,
"monthlyPensionAmount": 30565180,
"monthlyTrend": [
{
"lostSubscribers": 2,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6681667",
"status": "1",
"styleCode": "1",
"subscriberCount": 80,
"turnoverMonths": 1
}{
"address": "대전광역시 유성구",
"ceo_name": "김의중, 김도연",
"certificate": [
{
"cert_number": "20011522710986",
"changes": "",
"disclosure_date": "2001-02-27",
"first_cert_date": "2001-02-27",
"no": "1",
"type": "연구개발기업",
"valid_period": "2001-02-27 ~ 2003-02-26"
},
{
"cert_number": "031522021200110",
"changes": "",
"disclosure_date": "2003-05-30",
"first_cert_date": "2001-02-27",
"no": "2",
"type": "연구개발기업",
"valid_period": "2003-05-30 ~ 2005-05-29"
},
{
"cert_number": "051522021300220",
"changes": "",
"disclosure_date": "2005-05-30",
"first_cert_date": "2001-02-27",
"no": "3",
"type": "연구개발기업",
"valid_period": "2005-05-30 ~ 2007-05-29"
},
{
"cert_number": "20070101818",
"changes": "",
"disclosure_date": "2007-06-13",
"first_cert_date": "2001-02-27",
"no": "4",
"type": "연구개발유형",
"valid_period": "2007-05-30 ~ 2009-05-29"
},
{
"cert_number": "20090106890",
"changes": "",
"disclosure_date": "2009-07-21",
"first_cert_date": "2001-02-27",
"no": "5",
"type": "연구개발유형",
"valid_period": "2009-05-30 ~ 2011-05-29"
},
{
"cert_number": "20110104206",
"changes": "",
"disclosure_date": "2011-07-01",
"first_cert_date": "2001-02-27",
"no": "6",
"type": "연구개발유형",
"valid_period": "2011-05-30 ~ 2013-05-29"
},
{
"cert_number": "20130106869",
"changes": "",
"disclosure_date": "2013-07-05",
"first_cert_date": "2001-02-27",
"no": "7",
"type": "연구개발유형",
"valid_period": "2013-05-30 ~ 2015-05-29"
},
{
"cert_number": "20150103827",
"changes": "",
"disclosure_date": "2015-04-30",
"first_cert_date": "2001-02-27",
"no": "8",
"type": "연구개발유형",
"valid_period": "2015-05-30 ~ 2017-05-29"
},
{
"cert_number": "20170106547",
"changes": "",
"disclosure_date": "2017-06-13",
"first_cert_date": "2001-02-27",
"no": "9",
"type": "연구개발유형",
"valid_period": "2017-05-30 ~ 2019-05-29"
},
{
"cert_number": "20190105377",
"changes": "",
"disclosure_date": "2019-05-23",
"first_cert_date": "2001-02-27",
"no": "10",
"type": "연구개발유형",
"valid_period": "2019-05-30 ~ 2021-05-29"
},
{
"cert_number": "20210616020072",
"changes": "",
"disclosure_date": "2021-06-16",
"first_cert_date": "2001-02-27",
"no": "11",
"type": "연구개발유형",
"valid_period": "2021-05-30 ~ 2024-05-29"
},
{
"cert_number": "20240522020008",
"changes": "기업명, 대표자",
"disclosure_date": "2024-05-22",
"first_cert_date": "2001-02-27",
"no": "12",
"type": "연구개발유형",
"valid_period": "2024-05-30 ~ 2027-05-29"
}
],
"company_name": "HLB제넥스",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 11262505000,
"cost_of_sales": 7953333000,
"current_assets": 32711194000,
"current_liabilities": 52975507000,
"gross_profit": 4784356000,
"net_income": -27287097000,
"net_income_bs": -26860762000,
"non_current_assets": 57418165000,
"non_current_liabilities": 525354000,
"non_operating_expenses": 32211157000,
"non_operating_income": 4572479000,
"operating_profit": 351581000,
"revenue": 12737689000,
"sga_expenses": 4432775000,
"total_assets": 90129359000,
"total_equity": 36628498000,
"total_liabilities": 53500861000
},
"2023": {
"capital_stock": 11379215000,
"cost_of_sales": 9012337000,
"current_assets": 19459832000,
"current_liabilities": 34717492000,
"gross_profit": 5227156000,
"net_income": -9705504000,
"net_income_bs": -10398217000,
"non_current_assets": 41470742000,
"non_current_liabilities": 351521000,
"non_operating_expenses": 16959881000,
"non_operating_income": 6970384000,
"operating_profit": 283993000,
"revenue": 14239494000,
"sga_expenses": 4943164000,
"total_assets": 60930574000,
"total_equity": 25861561000,
"total_liabilities": 35069012000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [],
"main_products": "Lactase, Catalas, Lipase",
"phone": "042-862-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Field | Source A | Value A | Source B | Value B | Similarity |
|---|---|---|---|---|---|
| company_name | employment | 에이치엘비제넥스주식회사(HLBGenex,Inc.) | venture_detail | HLB제넥스 | 11% |